Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 351 - 400 out of 101,976

Document Document Title
WO/2018/065324A1
The present invention relates to lactic acid bacteria strains with the ability to tolerate antiseptics. The lactic acid bacteria strains have further the capacity to antagonize the growth of oral pathogens. Particularly, the lactic acid ...  
WO/2018/067599A1
Certain embodiments of the disclosure are directed to variant filamentous fungal cells, compositions thereof and methods thereof for increased production of one or more proteins of interest. More particularly, in certain embodiments, the...  
WO/2018/067825A1
Disclosed are compositions and methods relating to the treatment of a cancer via the induction of PDL1 and use of anti-PDL1 antibodies.  
WO/2018/067815A1
Compositions are provided that include a new Bacillus thuringiensis strain designated RTI545 for use in benefiting plant growth and controlling plant pests. In particular, the RTI545 strain is useful for controlling plant nematode, insec...  
WO/2018/067068A8
The present invention relates to methods of metabolic engineering to increase the levels of short branched-chain fatty acids (SBCFAs) produced by microorganisms such as yeast. More particularly, the invention provides methods to engineer...  
WO/2018/067887A1
Disclosed herein are compositions and methods for diagnosing fungal dysbiosis in the gut of a subject with cirrhosis that involves assaying a sample from the subject for bacterial taxa. These compositions and methods are based on the dis...  
WO/2018/067647A1
An improved stabilization buffer for use in the lyophilization of Neospora and other protozoans is disclosed. Also disclosed is an improved lyophilization method, which includes controlling ice nucleation during the freezing step.  
WO/2018/064758A1
The present invention relates to recombinant protein production in algal cells. In particular, the present invention provides methods for making recombinant polypeptides in association with accumulated lipid particles or chloroplasts. Th...  
WO/2018/067915A1
The present invention encompasses a micro-fluidic system having a closed-loop configuration in which inertial micro-fluidic separation of particles and/or cells is continuously repeated by feeding part of the output back to the input so ...  
WO/2018/066916A1
The present invention provides a novel Scenedesmus sp. algae, and an extract thereof. This extract of Scenedesmus sp. JD-052, which is a novel Scenedesmus sp. algae, shows a UV protection effect, and thus can be usefully used in the fiel...  
WO/2018/067068A1
The present invention relates to methods of metabolic engineering to increase the levels of short branched-chain fatty acids (SBCFAs) produced by microorganisms such as yeast. More particularly, the invention provides methods to engineer...  
WO/2018/066686A1
The purpose of the present invention is to provide a novel culturing method capable of efficiently producing spores. This culturing method is a method for culturing spore-forming bacteria by adding a spore inhibitor into a medium, the me...  
WO/2018/067846A1
Methods and compositions are provided for modulating expression of a target nucleic acid sequence within a non-E. coli cell. The method includes providing the cell with a guide RNA comprising a portion that is complementary to all or a p...  
WO/2018/062075A1
The present invention addresses the problem of providing a means for aseptically separating a suspending medium from a suspension. Provided is a tool equipped with at least: a hollow fiber-type separator for separating a liquid A from a ...  
WO/2018/062103A1
The present invention addresses the problem of providing novel FAD-GDH having high practicality. Provided is glucose dehydrogenase having the amino acid sequence of (a) or (b) as follows. (a) The amino acid sequence of SEQ ID NO. 1 in wh...  
WO/2018/059465A1
An anti-CD27 antibody, an antigen-binding fragment thereof, and a medical use of the same. Further, provided are a chimeric antibody comprising a CDR of the anti-CD27 antibody, a humanized antibody, a pharmaceutical composition comprisin...  
WO/2018/062573A1
The purpose of the present invention is to provide an efficient method for recovering cells such as microorganisms or animal cells; specifically, the present invention pertains to a method for recovering cells, said method including a st...  
WO/2018/060567A1
Process with the aim of preventing or slowing the appearance of unattractive signs, generated by the pollutants present in the atmosphere, on the skin, the scalp, the hair or the mucous membranes, or indeed of eliminating them, comprisin...  
WO/2018/058865A1
Provided is a dynamic fluid shear technology-based cell-wall breaking method for spirulina, comprising the following steps: (1) sucking spirulina in the surface layer of a water body by means of a plurality of fixed vortex well spirulina...  
WO/2018/064037A1
Methods of culturing microalgae in acetate toxicity conditions to induce the uptake of acetate, control contamination, increase the metabolic rate, increase the respiration rate, increase the accumulation of lipids, and decreasing the ac...  
WO/2018/062178A1
In the present invention, mutations involving amino acid substitution were introduced into various locations of diphosphomevalonate decarboxylase (MVD), and many variants of MVD were prepared. Then, regarding the variants, an enzymatic a...  
WO/2018/062203A1
The present invention provides an insect odorant receptor co-receptor that exhibits excellent detection sensitivity of odorants when bound with an odorant receptor to form an odorant receptor complex. This odorant receptor co-receptor is...  
WO/2018/058249A1
The present disclosure provides a system and method for identifying and targeting individual cells within a cell population for selective extraction of cellular content and a digital microfluidic device having at least one hydrophilic si...  
WO/2018/064338A1
Methods and compositions for the selection of nucleic acid processing and other enzymes, and more specifically for the selection of DNA polymerases and other enzymes with desired properties employing the directed evolution of enzymes by ...  
WO/2018/062914A1
The present application relates to novel lactobacillus sakei and a composition comprising the same.  
WO/2018/061719A1
The invention provides a method of measuring simply and accurately a microbial count in a sample. Namely, a method of measuring a microbial count including a step of blending a composition for preparing a culture medium for a microbial c...  
WO/2018/062201A1
The present invention provides an odorant receptor complex formed from an insect odorant receptor and an insect odorant receptor co-receptor, and which exhibits excellent detection sensitivity to odorous substances. This odorant receptor...  
WO/2018/062015A1
Provided is a lipid manufacturing method in which transformants into which are introduced genes coding for at least one protein selected from a group formed of proteins (A)-(C), described below, are cultured and in which fatty acids or l...  
WO/2018/062175A1
The purpose of the present invention is to provide molecularly altered adiponectin that can be produced as a uniform product, and has the same or greater activity compared to natural adiponectin. This molecularly altered adiponectin is p...  
WO/2018/064036A1
Methods of growing organisms in the Thraustochytriaceae family using a supply of at least one of acetate and acetic acid as an organic carbon source are described. Embodiments include using acetate or acetic acid in combination with othe...  
WO/2018/062790A1
Disclosed in the present specification is a novel microorganism Chryseobacterium camelliae Dolsongi-HT1 with keratinolytic activity. The novel microorganism was isolated from green tea leaves and has outstanding keratinolytic activity at...  
WO/2018/062225A1
The present invention addresses the problem of providing a promotor capable of efficiently expressing genes, in Bifidobacterium genus bacteria. In the present invention, a promotor including a TTGNNN motif and a TATANT motif located down...  
WO/2018/060708A1
A method of analysing a sample taken from a dialysis patient for the presence of microorganisms, said method comprising the steps of: (i) contacting the sample with (I) a first reporting means comprising: (a1) an indicator compound; and ...  
WO/2018/062822A1
The present invention relates to a Xylaria grammica EL 000614 strain exhibiting nematicidal activity against Meloidogyne spp., and a use thereof. The Xylaria grammica EL 000614 strain for controlling nematodes, according to the present i...  
WO/2018/064165A2
Provided herein are methods and compositions for the treatment of cancer by modulating the microbiome to enhance the efficacy of immune checkpoint blockade. The microbiome may be modulated by the administration of butyrate and/or butyrat...  
WO/2018/058119A1
Provided herein are edible compositions that mimic the organoleptic properties of seafood, as well as methods of making and using the same.  
WO/2018/056374A1
The problem to be addressed by the present invention is to provide improved recombinant FcγRIIb and FcγRIIa that do not require refolding and exhibit high productivity and thermal stability, and to provide a method for producing the sa...  
WO/2018/056388A1
There is a demand for a novel method for producing sesaminol glycoside and sesaminol. The present invention provides a method for producing sesaminol glycoside and/or sesaminol, the method comprising a step for cleaving at least one glyc...  
WO/2018/055282A1
The invention relates to a bioreactor comprising a tank (100) capable of being operated for a working period, said tank (100) being intended to receive a culture medium comprising a cellular culture of photosynthetic microorganisms, a li...  
WO/2018/055282A4
The invention relates to a bioreactor comprising a tank (100) capable of being operated for a working period, said tank (100) being intended to receive a culture medium comprising a cellular culture of photosynthetic microorganisms, a li...  
WO/2018/054244A1
A xylanase mutant and application thereof. The amino acid sequence of the xylanase mutant is as shown in SEQ ID No:1; and the xylanase mutant is obtained by coding amino acids in fungal Neocallimastigomycota xylanase amino acid sequenc...  
WO/2018/056284A1
The purpose of the present invention is to provide: a novel composition and solvent for promoting the production of bacteria belonging to the genus Faecalibacterium; and a method for promoting the production of bacteria belonging to the ...  
WO/2018/057879A1
The present invention relates to recombinant vectors, modified microorganisms, and methods for omega-3 polyunsaturated fatty acid production.  
WO/2018/055587A1
Method for the bioremediation of waters contaminated with hydrocarbons, which comprises putting said contaminated waters in contact with at least one polyhydroxyalkanoate (PHA) and allowing microorganisms present in said contaminated wat...  
WO/2018/054059A1
The present invention belongs to the technical field of industrial microbiology. Disclosed is a method of producing surfactin by applying Bacillus amyloliquefaciens. By applying Bacillus amyloliquefaciens of CGMCC No.12593 obtained by sc...  
WO/2018/055563A1
The present invention relates to a method for heterologously expressing an ornithine acyl-ACP N-acyltransferase in a microorganism, wherein the expression of the ornithine acyl-ACP N-acyltransferase protein catalyses the synthesis of lys...  
WO/2018/056794A1
The present invention relates to a microorganism having improved metabolic capacity of acetic acid and, more particularly, to a mutant microorganism, preferably Escherichia coli, which can utilize acetic acid as a sole carbon source as a...  
WO/2018/056470A1
The purpose of the present invention is to provide a novel compound that selectively damages cells that have become mesenchymal cells by epithelial-mesenchymal transition. Compounds, etc., represented by formula (I). [In the formula, R1 ...  
WO/2018/055009A1
An alga, particularly a diatom, comprising one or more selected from the group consisting of: a therapeutic agent (such as an immunogenic agent; antibody; anti-microbial agent; anti-parasitic agent and appetite promoter); an exogenous nu...  
WO/2018/051895A1
Provided is a drug composition and food composition for treating or preventing a skin disease caused by the abnormal proliferation of a skin bacterium or caused by pathogenic microbe infection. This composition includes lactic acid bacte...  

Matches 351 - 400 out of 101,976